Received 8/5/97 Accepted 8/12/97

1. W. W. Barrow: Contributing factors of pathogenesis in the Mycobacterium avium complex. Res. Microbiol. 142, 427-433 (1991)

2. C. R. J. Horsburgh: Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New Eng J. Med. 324, 1332-1338 (1991)

3. S. D. Nightingale, L. T. Byrd, P. M. Southern, J. D. Jockusch, S. X. Cal & B. A. Wynne: Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus positive patients. J. Infect. Dis. 165, 1082-1085 (1992)

4. L. E. Bermudez: Immunobiology of Mycobacterium avium Infection. Eur. J. Clin. Microbiol. Infect. Dis. 13, 1000-1006 (1994)

5. C. B. Inderlied, C. A. Kemper & L. E. Bermudez: The Mycobacterium avium complex. Clin. Microbiol. Rev. 6, 266-310 (1993)

6. M. R. McNeil & P. J. Brennan: Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. Res. Microbiol. 142, 451-463 (1991)

7. D. E. Minnikin. The Biology of the Mycobacteria. Academic Press, London (1982)

8. D. E. Minnikin: Chemical principles in the organization of lipid components in the mycobacterial cell envelope. Res. Microbiol. 142, 423-427 (1991)

9. N. Rastogi: Recent observations concerning structure and function relationships in the mycobacterial cell envelope: elaboration of a model in terms of mycobacterial pathogenicity, virulence and drug resistance. Res. Microbiol 142, 464-476 (1991)

10. P. Draper: The structure of the mycobacterial cell envelope is not yet understood. Res. Microbiol. 142, 420-422 (1991)

11. L. Barksdale & K. S. Kim: Mycobacterium. Bacteriol. Rev. 41, 217-372 (1977)

12. W. W. Barrow, B. P. Ullom & P. J. Brennan: Peptidoglycolipid nature of the superficial cell wall sheath of smooth-colony-forming mycobacteria. J. Bacteriol. 144, 814-822 (1980)

13. W. W. Barrow & P. J. Brennan: Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens. J. Bacteriol. 150, 381-384 (1982)

14. P. Draper: The mycoside capsule of Mycobacterium avium 357. J. Gen. Microbiol. 83, 431-433 (1974)

15. Y. Fukunishi, S. Okada, M. Nishiura & K. Kohsaka: Ultrastructural features of the multiplication of human and murine leprosy bacilli in macrophages of nude mice. Int. J. Lepr. 50, 68-75 (1982)

16. S. Rulong, A. P. Aguas, P. P. DaSilva & M. T. Silva: Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamellar structure: Freeze fracture analysis of infected mouse liver. Infect. Immun. 59, 3895-3902 (1991)

17. P. Draper & R. J. W. Rees: Electron-transparent zone of mycobacteria may be a defense mechanism. Nature (London) 228, 860-861. (1970)

18. P. Draper & R. J. W. Rees: The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host. J. Gen. Microbiol. 77, 79-87 (1973)

19. M. J. Tereletsky & W. W. Barrow: Postphagocytic detection of glycopeptidolipids associated with the superficial L₁ layer of Mycobacterium intracellulare. Infect. Immun. 41, 1312-1321 (1983)

20. P. J. Brennan & M. B. Goren: Structural studies on the type-specific antigens and lipids of the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum serocomplex. J. Biol. Chem. 254, 4205-4211 (1979)

21. W. W. Barrow, E. L. Wright, K. S. Goh & N. Rastogi: Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium. Antimicrob. Agents Chemother. 37, 652-661 (1993)

22. J. T. Belisle, M. R. McNeil, D. Chatterjee, J. M. Inamine & P. J. Brennan: Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium. J. Biol. Chem. 268, 10510-10516 (1993)

23. M. Rivière, G. Puzo, E. L. Wright & W. W. Barrow: Unique phenylalanine-containing lipopeptide isolated from a rough-colony variant of Mycobacterium avium. Eur. J. Biochem. 241, 682-690 (1996)

24. P. J. Brennan & H. Nikaido: The envelope of mycobacteria. Annu. Rev. Biochem. 64, 29-63 (1995)

25. S. W. Hunter, H. Gaylord & P. J. Brennan: Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J. Biol. Chem. 261, 12345-12351 (1986)

26. A. Lemassu & M. Daffé: Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem. J. 297, 351-357 (1994)

27. J. J. Ellner & T. M. Daniel: Immunosuppression by mycobacterial arabinomannan. Clin. Exp. Immunol. 35, 250-257 (1979)

28. I. Tsuyuguchi, H. Kawasumi, T. Takashima, T. Tsuyuguchi & S. Kishimoto: Mycobacterium avium-Mycobacterium intracellulare complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Infect. Immun. 58, 1369-1378 (1990)

29. I. Hines, M.E., J. M. Jaynes, S. A. Barker, J. C. Newton, F. M. Enright & I. T.G. Snider: Isolation and partial characterization of glycolipid fractions from Mycobacterium avium serovar 2 (Mycobacterium paratuberculosis 18) that inhibit activated macrophages. Infect. Immun. 61, 1-7 (1993)

30. L. D. Sibley, L. B. Adams & J. L. Krahenbuhl: Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan. Clin. Exper. Immunol. 80, 141-148 (1990)

31. L. D. Sibley, S. W. Hunter, P. J. Brennan & J. L. Krahenbuhl: Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect. Immun. 56, 1232-1236 (1988)

32. G. Kaplan, R. R. Gandhi, D. E. Weinstein, W. R. Levis, M. E. Patarroyo, P. J. Brennan & Z. A. Cohn: Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J. Immunol. 138, 3028-3034 (1987)

33. C. Moreno, A. Mehlert & J. Lamb: The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin. Exp. Immunol. 74, 206-210 (1988)

34. A. Molloy, G. Gaudernack, W. R. Levis, Z. A. Cohn & G. Kaplan: Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87, 973-977 (1990)

35. C. S. Chujor, B. Kuhn, B. Schwerer, H. Bernheimer, W. R. Levis & D. Bevec: Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen. Clin. Exp. Immunol. 87, 398-403 (1992)

36. D. Chatterjee, A. D. Roberts, K. Lowell, P. J. Brennan & I. M. Orme: Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 60, 1249-1253 (1992)

37. C. Moreno, J. Taverne, A. Mehlert, C. A. W. Bate, R. J. Brealy, A. Meager, G. A. W. Rook & J. H. L. Playfair: Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumor necrosis factor from human and murine macrophages. Clin. Exp. Immunol. 76, 240-245 (1989)

38. M. G. Bradbury & C. Moreno: Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages. Clin. Exp. Immunol. 94, 57-63 (1993)

39. S. Ilangumaran, S. Arni, M. Poincelet, J.-M. Theler, P. J. Brennan, Nasir-ud-Din & D. C. Hoessli: Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J. Immunol. 155, 1334-1342 (1995)

40. A. Venisse, J.-J. Fournié & G. Puzo: Mannosylated lipoarabinomannan interacts with phagocytes. Eur. J. Biochem. 231, 440-447 (1995)

41. L. S. Schlesinger, L. R. Hull & T. M. Kaufman: Binding of their terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152, 4070-4079 (1994)

42. L. C. Hooper & W. W. Barrow: Decreased mitogenic response of murine spleen cells following intraperitoneal injection of serovar-specific glycopeptidolipid antigens from the Mycobacterium avium complex. Adv. Exper. Med. Biol. 239, 309-325 (1988)

43. P. E. Brownback & W. W. Barrow: Modified lymphocyte response to mitogens after intraperitoneal injection of glycopeptidolipid antigens from Mycobacterium avium complex. Infect. Immun. 56, 1044-1050. (1988)

44. L. C. Hooper, M. M. Johnson, V. R. Khera & W. W. Barrow: Macrophage uptake and retention of radiolabeled glycopeptidolipid antigens associated with the superficial L₁ layer of Mycobacterium intracellulare serovar 20. Infect. Immun. 54, 133-141 (1986)

45. J. L. Woodbury & W. W. Barrow: Radiolabelling of Mycobacterium avium oligosaccharide determinant and use in macrophage studies. J. Gen. Microbiol. 135, 1875-1884 (1989)

46. B. Gjata, C. Hannoun, H.-J. Boulouis, T. Neway & C. Pilet: Adjuvant activity of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on the immunogenic and protective effects of an inactivated influenza vaccine. C.R. Acad. Sci. Paris 317, 257-263 (1994)

47. S. Vincent-Naulleau, T. Neway, D. Thibault, F. Barrat, H. J. Boulouis & C. Pilet: Effects of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on granulomacrophage progenitors. Res. Immunol. 146, 363-371 (1995)

48. P. H. Lagrange, M. Fourgeaud, T. Neway & C. Pilet: Mycobacterial polar glycopeptidolipids enhance resistance to experimental murine candidiasis. C.R. Acad. Sci. Paris 318, 359-365 (1995)

49. P. J. Brennan & W. W. Barrow: Evidence for species-specific lipid antigens in Mycobacterium leprae. Int. J. Lepr. 48, 382-387 (1980)

50. V. Mehra, P. J. Brennan, E. Rada, J. Convit & B. R. Bloom: Lymphocyte suppression in leprosy induced by unique M, leprae glycolipid. Nature 308, 194-196 (1984)

51. M. Vachula, T. J. Holzer & B. R. Andersen: Suppression of monocyte oxidative responses by phenolic glycolipid I of Mycobacterium leprae. J. Immunol. 142, 1696-1701 (1989)

52. J. Fournie, E. Adams, R. J. Mullins & A. Basten: Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect. Immun. 57, 3653-3659 (1989)

53. L. D. Sibley & J. L. Krahenbuhl: Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon. Infect. Immun. 55, 446-450 (1987)

54. W. W. Barrow, T. L. Davis, E. L. Wright, V. Labrousse, M. Bachelet & N. Rastogi: Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect. Immun. 63, 126-133 (1995)

55. W. W. Barrow, J. P. Carvalho de Sousa, T. L. Davis, E. L. Wright, M. Bachelet & N. Rastogi: Immunomodulation of human peripheral blood mononuclear cells by defined lipid fractions of Mycobacterium avium. Infect. Immun. 61, 5286-5293 (1993)

56. M. Pourshafie, Q. Ayub & W. W. Barrow: Comparative effects of Mycobacterium avium glycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cells. Clin. Exper. Immunol. 93, 72-79 (1993)

57. T. K. VanHeyningen, H. L. Collins & D. G. Russell: IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J. Immunol. 158, 330-337 (1997)

58. T. L. Davis, S. Z. V. GInkel, L. R. Bland, E. L. Wright & W. W. Barrow. Eicosanoid and Cytokine Profiles of the Mono MAc 6 Monocytic Human Cell Line Induced by Mycobacterial Lipids, Abstract U178. ASM, New Orleans (1996)

59. E. L. W. Barrow, S. Z.-V. Ginkel & W. W. Barrow. Evaluation of cytokine responses M. avium lipids with monocyte and T-lymphocyte cell lines, Abstract U-19. American Society for Microbiology, Miami (1997)

60. M. Goren & P. J. Brennan. Mycobacterial lipids: chemistry and biological activities. In: Tuberculosis. Eds: Youmans, G. P., W.B. Saunders Co., Philadelphia (1979)

61. E. L. Wright & W. W. Barrow: Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucose. Res. Microbiol. 142, 597-608 (1991)

62. M. McNeil, A. Y. Tsang & P. J. Brennan: Structure and antigenicity of the specific oligosaccharide of Mycobacterium avium serotype 4, the dominant mycobacterium isolated from patients with acquired immune deficiency syndrome. J. Biol. Chem. 262, 2630-2635 (1987)

63. I. Vergne, M. Prats, J.-F. Tocanne & G. Lanéelle: Mycobacterial glycopeptidolipid interactions with membranes: a monolayer study. FEBS Letters 375, 254-258 (1995)

64. B. Wong, F. F. Edwards, T. E. Kiehn, E. Whimbey, H. Donnelly, E. M. Bernard, J. W. M. Gold & D. Armstrong: Continuous high-grade Mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am. J. Med. 78, 35-40 (1985)

65. S. Daugelat & S. H. E. Kaufmann: Role of Th1 and Th2 cells in bacterial infections. Chem. Immunol. 63, 66-97 (1996)

66. Z. Toossi: Cytokine circuits in tuberculosis. Infectious Agents and Disease 5, 98-107 (1996)

67. S. Romagniani: Human Th1 and Th2 subsets: doubt no more. Immunol. Today 12, 256-257 (1991)

68. R. Appelberg & J. Pedrosa: Induction and expression of protective T cells during Mycobacterium avium infections in mice. Clin. Exp. Immunol. 87, 379-385 (1992)

69. A. G. Castro, P. Minoprio & R. Appelberg: The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice. Immunology 85, 556-561 (1995)

70. I. M. Orme, A. D. Roberts, S. K. Furney & P. S. Skinner: Animal and cell-culture models for the study of mycobacterial infections and treatment. Eur. J. Clin. Microbiol. Infect. Dis. 13, 994-999 (1994)

71. R. Appleberg, A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme & P. Minoprio: The role of gamma interferon and tumor necrosis factor-alpha during the T cell independent and dependent phases of Mycobacterium avium infection. Infect. Immun. 62, 3962-3970 (1994)

72. K. Arai, F. Lee, A. Miyajima, S. Miyatake, N. Arai & T. Yokota: Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59, 783-794 (1990)

73. C. A. Feghali & T. M. Wright: Cytokines in acute and chronic inflammation. Frontiers in Biosciences 2, 12-26 (1997)

74. A. Meager. Cytokines. Open University Press, Milton Keynes (1990)

75. R. G. P. Pugh-Humphreys & A. W. Thomson. Cytokines and their receptors as potential therapeutic targets. In: The Cytokine Handbook. Eds: Thomson, A. W., Harcourt Brace & Company, London (1994)

76. G. Lanéelle & M. Daffé: Mycobacterial cell wall and pathogenicity: A lipidologist's view. Res. Microbiol. 142, 433-437 (1991)

77. N. Rastogi & W. W. Barrow: Cell envelope constituents in the multifaceted nature of M. avium pathogenicity and drug resistance. Res. Microbiol. 145, 243-252 (1994)

78. L. E. Bermudez: Production of transforming growth factor-b by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma. J. Immunol. 150, 1838-1845 (1993)

79. L. E. Bermudez & J. Champsi: Infection with Mycobacterium avium induces production of interleukin 10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect. Immun. 61, 3093-3097 (1993)

80. D. K. Blanchard, M. B. Michelini-Norris, C. A. Pearson, C. S. Freitag & J. Y. Djeu: Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes. Blood 77, 2218-2224 (1991)

81. D. K. Blanchard, M. B. Michelini-Norris, C. A. Pearson, S. McMillen & J. Y. Djeu: Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF. Infect. Immun. 59, 2396-2402 (1991)

82. M. B. Michelini-Norris, D. K. Blanchard, C. A. Pearson & J. Y. Djeu: Differential release of interleukin (IL)-1alpha, IL-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare complex. J. Infect. Dis. 165, 702-709 (1992)

83. H. Shiratsuchi, Z. Toossi, M. A. Mettler & J. J. Ellner: Colonial morphotype as a determinant of cytokine expression by human monocytes infected with Mycobacterium avium. J. Immunol. 150, 2945-2954 (1993)

84. M. Denis & E. O. Gregg: Modulation of Mycobacterium avium growth in murine macrophages: Reversal of unresponsiveness to interferon-gamma by indomethacin or interleukin-4. J. Leukoc. Biol. 49, 65-72 (1991)

85. S. E. Ealick, Y. S. Babu, C. E. Bugg, M. D. Erion, W. C. Guida, J. A. Montgomery & I. J.A. Secrist: Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. Proc. Natl. Acad. Sci, USA 88, 11540-11544 (1991)

86. C. K. Edwards, III, H. B. Hedegaard, A. Zlotnik, P. R. Gangadharam, J. R.B. Johnston & M. J. Pabst: Chronic infection due to Mycobacterium intracellulare in mice: Association with macrophage release of prostaglandin E₂ and reversal by injection of indomethacin, muramyl dipeptide, or interferon-g. J. Immunol. 136, 1820-1827 (1986)

87. N. Rastogi, M. Bachelet & J. P. Carvalho de Sousa: Intracellular growth of Mycobacterium avium in human macrophages is linked to the increased synthesis of prostaglandin E2 and inhibition of the phagosome-lysosome fusions. FEMS Microbiol. Immunol. 89, 273-280 (1992)

88. N. Venkataprasad, H. Shiratsuchi, J. L. Johnson & J. J. Ellner: Induction of prostaglandin E2 by human monocytes infected with Mycobacterium avium complex-modulation of cytokine expression. J. Infect. Dis 174, 806-811 (1996)

89. C. Fréhel, C. de Chastellier, T. Lang & N. Rastogi: Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect. Immun. 52, 252-262 (1986)

90. H. M. Abdel-Dayem, W. S. Omar, M. Aziz, V. Labombardi, L. Difabrizio, J. S. Kempf & J. Gillooley: Disseminated Mycobacterium avium complex. Review of Ga-67 and TI-210 scans and autopsy findings. Clin. Nucl. Med. 21, 547-556 (1996)

91. T. E. Kiehn, F. F. Edwards, P. Brannon, A. Y. Tsang, M. Maio, J. W. M. Gold, E. Whimbey, B. Wong, J. K. McClatchy & D. Armstrong: Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis of blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J. Clin. Microbiol. 21, 168-173. (1985)

92. M. Denis & E. Ghadirian: Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens. Clin. Exp. Immunol. 97, 76-82 (1994)

93. V. Navikas, J. Link, C. Persson, T. Olsson, B. Höjeberg, Å. Ljungdahl, H. Link & B. Wahren: Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. J. Acquir. Immune Defic. Syndr. 9, 484-489 (1995)

94. G. Lanéelle & J. F. Tocanne: Evidence for penetration in liposomes and mitochondrial membranes of a fluorescent analogue of Cord factor. Europ. J. Biochem. 109, 177-182 (1980)

95. D. E. S. Stewart-Tull, M. Davies & D. M. Jackson: The binding of adjuvant-active mycobacterial peptidoglycolipids and glycopeptides to mammalian membranes and their effect on artificial lipid bilayers. Immunology 34, 57-67 (1978)

96. R. C. Roozemond, P. K. Das & M. Halperin: Effect of mycobacterial lipids on membrane fluidity and natural killer cell-mediated cytotoxicity. Ann. Immunol. (Inst. Pasteur) 135D, 247-255 (1984)

97. R. C. Roozemond, M. Halperin & P. K. Das: Inhibition of natural killer cell-mediated cytotoxicity by lipids extracted from Mycobacterium bovis BCG. Clin. Exp. Immunol. 62, 482-490 (1985)

98. A. Sut, S. Sirugue, S. Sixou, F. L.-Ghazal, J.-F. Tocanne & G. Lanéelle: Mycobacteria glycolipids as potential pathogenicity effectors: Alteration of model and natural membranes. Biochem. 29, 8498-8502 (1990)

99. S. K. Tassell, M. Pourshafie, E. L. Wright, M. G. Richmond & W. W. Barrow: Modified lymphocyte response to mitogens induced by lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptidolipids. Infect. Immun. 60, 706-711 (1992)

100. J. A. Levy: Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289 (1993)

101. T. Matsuyama, N. Kobayashi & N. Yamamoto: Cytokines and HIV infections: is AIDS a tumor necrosis factor disease? AIDS 5, 1405-1417 (1991)

102. M. Baier, A. Werner, N. Bannert, K. Metzner & R. Kurth: HIV suppression by interleukin-16. Nature 378, 563-565 (1995)

103. M. M. Bertagnolli, B.-Y. Lin, D. Young & S. H. Hermann: IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149, 3778-3783 (1992)

104. R. Manetti, P. Parronchi, M. G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri & S. Romagnani: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204 (1993)

105. R. Manetti, F. Gerosa, M. G. Giudizi, R. Biagiotti, P. Parronchi, M.-P. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani & G. Trinchieri: Interleukin 12 induces stable priming for interferon-g (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J. Exp. Med. 179, 1273-1283 (1994)

106. A. Weiss, R. L. Wiskocil & J. D. Stobo: The role of T3 surface molecules in the activation of human cells: a two-stimulus requirement for IL2 production reflects events occurring at a pre-translational level. J. Immunol. 133, 123-128 (1984)

107. P. Openshaw, E. E. Murphy, N. A. Hosken, V. Maino, K. Davis, K. Murphy & A. O'Garra: Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182, 1357-1367 (1995)

108. S. Romagniani: Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12, 227-257 (1994)

109. J. B. A. G. Haanen, R. d. Malefijt, P. C. M. Res, E. M. Kraakman, T. H. M. Ottenhoff, R. R. P. deVries & H. Spits: Selection of a human T helper type 1-like T cell subset by mycobacteria. J. Exp. Med. 174, 583-592 (1991)

110. R. E. Sacco, R. J. Jensen, J. Weinstock, R. G. Lynch & M. O. Dailey: Cytokine secretion and adhesion molecule expression by granuloma T lymphocytes in Mycobacterium avium infection. Amer. J. Pathol. 148, 1935-1948 (1996)

111. M. Dubois, K. A. Gilles, J. K. Hamilton, P. A. Rebers & F. Smith: Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-356 (1966)

112. Z. Dische & L. B. Shettles: A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J. Biol. Chem. 175, 595-603. (1948)

113. P. J. Brennan, M. Souhrada, B. Ullom, J. K. McClatchy & M. B. Goren: Identification of atypical mycobacteria by thin-layer chromatography of their surface antigens. J. Clin. Microbiol. 8, 374-379 (1978)